recombinant tPA

recombinant tPA

Mentioned in ?
References in periodicals archive ?
The modes of therapy available include the administration of intravenous tissue plasminogen activator (tPA) or endovascular therapy involving either intraarterial thrombolysis with recombinant tPA, mechanical clot disruption or clot retrieval.
Glycan structures of human recombinant tPA produced by Chinese hamster ovary cells have been reported to be core fucosylated and mono-, di-, and trisialylated (20-21).
025, and 0 ng/mL recombinant tPA, MME, DPP-4, and TIMP-1, respectively.
The glycan profiles established for recombinant tPA, DPP-4, and TIMP-1 by the single assays were similar to the profiles established by the multiplex assays (Fig.
Transformation of origami B (DE3) cells and expression of recombinant tPA
Expression of recombinant tPA was induced by addition of IPTG as described above.
of Naples, Italy) notes that the only current drug therapy for stroke is a thrombolytic strategy aimed at reducing the failure of arterial oxygen and glucose delivery to the brain tissue by delivering the clot busting- drug recombinant tPA shortly after the onset of symptoms.
Food and Drug Administration for acute ischemic stroke, recombinant TPA, such as alteplase and reteplase, are being used off label for intraarterial lysis in ischemic stroke.

Full browser ?